Contracts › HT942524C0049
HT942524C0049: Sbir Phase Iii Proposal No. JW230017 Titled, "Optimized, Field-Stable Glycopolymer-Mimicking Polysaccharide to Prevent Morbidity and Mortality in Exposure to Ionizing Radiation or Nuclear Injury"
Awarded to Synedgen, Inc. by Defense Health Agency.
$2.3Mobligated
$2.3Mpotential value
19 September 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942524C0049 |
|---|---|
| Awardee | Synedgen, Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 20 September 2024 to 19 September 2026 |
| Potential end | 19 September 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record